Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,678 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06353594Recruiting
Fewer stents vs usual stents for STEMI heart attack
This study compares using fewer stents versus the usual number of stents during emergency angioplasty for a severe heart attack (STEMI). It aims to see if a less-is-more approach is safe and effective.
Huelva, HuelvaAges 18 years+ - NCT06353542Recruiting
Glaucoma screening with AI for people with family history
This trial uses an artificial intelligence (AI) program to screen for glaucoma in people who have a family history of the disease. It aims to catch glaucoma early, when it can be treated more effectively.
Barcelona, BarcelonaAges 40–80 - NCT06353607Recruiting
Genetics of aortic aneurysm and dissection
This study looks at the genetic reasons behind aortic aneurysms and sudden aortic tears. By studying people who had surgery at the University Hospital Basel, researchers hope to find inherited patterns that could help predict and prevent these serious conditions.
BaselAges 18 years+ - NCT06353685RecruitingPhase 2
Less radiation after surgery for oral cancer with good response
This trial is testing whether giving less radiation after surgery is safe and effective for people with oral cancer whose surgery results were very good (no cancer cells or very few left). It aims to reduce side effects while still preventing cancer from coming back.
GuangzhouAges 18–80 - NCT06354140RecruitingPhase 2
Tislelizumab plus S-1 for esophageal cancer after surgery
This trial tests a combination of the immunotherapy drug tislelizumab and the chemotherapy drug S-1 for people with a specific type of esophageal cancer that still has some cancer cells in the main tumor but no cancer in lymph nodes after surgery. The goal is to see if this treatment can help prevent the cancer from coming back.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT06354439RecruitingPhase 4
Letrozole for ectopic pregnancy treatment
This trial tests whether letrozole (a hormone-blocking pill) can treat an ectopic pregnancy safely and effectively, allowing you to keep your ability to have children. It is an alternative to methotrexate, and you'll be randomly assigned to one of the two treatments.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT06354218RecruitingPhase 2
Serplulimab plus chemoradiation for older adults with esophageal cancer
This trial tests a new immunotherapy drug called serplulimab combined with standard chemotherapy and radiation for older adults with locally advanced esophageal cancer. It aims to see if this combination can help shrink tumors and improve outcomes without prior cancer treatment.
Nanjing, JiangsuAges 75 years+ - NCT06354764Recruiting
Study on emergency department visits in Europe
This study looks at which patients who visit the emergency department (ED) end up being admitted to the hospital. The goal is to understand patterns and reasons for hospitalization from the ED.
TorinoAges 18 years+ - NCT06354738Recruiting
Endometrial cancer study with genetic and surgical insights
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
LeuvenAges 18 years+ - NCT06355050Recruiting
Short, intense radiation for prostate cancer
This trial tests a very short course of daily radiation that adapts to your body's changes. It aims to be just as effective as standard treatment but more convenient.
JenaAges 18–120 - NCT06355206Recruiting
Recurrent acute pancreatitis study and treatment
This trial follows the natural course of recurrent acute pancreatitis and tests how well treatments work for it.
Shanghai, Shanghai MunicipalityAges Any age - NCT06355076Recruiting
New Urethral Reconstruction in Robotic Prostate Removal
This trial tests a new way to rebuild the urethra during robot-assisted prostate removal surgery for prostate cancer. It may help people whose cancer hasn't spread too far or has been reduced enough for surgery.
Jinan, ShandongAges 18 years+ - NCT06355245Recruiting
Early cancer detection study for unexplained symptoms
This study looks for early signs of cancer in people who have unexplained symptoms like extreme tiredness, weight loss, fever, or abnormal lab tests. You will be monitored and tested to see if markers can find cancer sooner.
StockholmAges 18 years+ - NCT06355609RecruitingPhase 2
Targeted therapy for advanced EGFR-mutant lung cancer
This trial tests a combination of two targeted pills (sunvozertinib and anlotinib) as a first treatment for people with advanced lung cancer that has a specific EGFR mutation. It aims to see if this combination works better than current standard treatments.
Changsha, HunanAges 18 years+ - NCT06356662RecruitingPhase 1
Testing tenofovir for Parkinson's disease
This trial is testing if a medicine called tenofovir, usually used for HIV and hepatitis B, can help people with early-stage Parkinson's disease. It's for people who are under 65 and have no other major health issues.
Hangzhou, ZhejiangAges 18–65 - NCT06356220Recruiting
Gluten-free nutrition for kids with celiac disease
This study helps children with newly diagnosed celiac disease eat a healthier gluten-free diet by reducing processed foods. It aims to improve nutrition and overall health.
Boston, MassachusettsAges 2–18 - NCT06356584RecruitingPhase 2
A drug combination with or without radiation for advanced colorectal cancer
This trial tests a new drug combo (fruquintinib and sintilimab) with or without radiation for people with colorectal cancer that has spread to the liver and has not responded to earlier treatments.
Jinan, ShandongAges 18–75 - NCT06357741Recruiting
Desuzumab for knee osteoarthritis
This study tests a new medicine called Desuzumab for knee osteoarthritis. It looks at whether the medicine can help reduce pain and improve joint function.
Wuhan, HubeiAges 45–75 - NCT06357780Recruiting
Comparing two breath-timing methods for breathing masks in adults
This study compares two ways of timing a breathing mask's support to match your own breaths. If you're in the ICU or ER and need help breathing for at least 2 more hours, this trial may test which method works better.
IzmirAges 18 years+ - NCT06358040Recruiting
Opioid dispenser after back surgery trial
This trial tests a special device that gives you pain medication (opioids) after back surgery, instead of a prescription. It may help you use just the right amount of pain medicine, and you'll use your smartphone for follow-up visits.
New York, New YorkAges 18 years+ - NCT06358209Recruiting
Washing the brain for infection treatment
This study tests whether washing out the infected fluid spaces in the brain (ventricular irrigation) can safely treat a serious brain infection (ventriculitis). It is for adults with a confirmed infection and fever who are stable enough for the procedure.
Hefei, AnhuiAges 18–65 - NCT06358222Recruiting
Lung cancer trial testing blood test and PET scan for spread
This trial studies if a blood test that looks for tumor DNA combined with a PET-CT scan can better predict if lung cancer has spread to lymph nodes. It may help guide treatment decisions for people with non-small cell lung cancer that hasn't been treated yet.
ShanghaiAges 18–75 - NCT06358248Recruiting
Registry for customized endografts in complex aortic aneurysms
This registry tracks patients with complex abdominal aortic aneurysms who receive a physician-modified endograft. It aims to collect data on how well this tailored device works to treat aneurysms that standard grafts cannot handle.
PadovaAges 18–100 - NCT06359548Recruiting
Repositioning the retina's inner layer for macular hole repair
This study tests a surgery for people with a small macular hole (a break in the retina's center). The surgeon repositions the inner layer of the retina to help the hole heal. It may be an option if you are between 50 and 80 and have not had eye surgery before.
ShanghaiAges 50–90
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,678 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.